Clinical Trial

STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the safety and efficacy of Siegel™ TAVR System in the treatment of subjects with symptomatic severe native aortic stenosis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-10; most recent amendment 2026-04-03.
Status change: Not Yet Recruiting → Recruiting 2026-04-03
Trial Details
NCT Number NCT07278310
Lead Sponsor MiRus
Conditions Symptomatic Severe Native Aortic Stenosis, Aortic Stenosis
Enrollment 1,025 participants
Start Date 2026-04
Primary Completion 2028-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-04-09